Skip to main content

Artemis Funds (Lux) – US Select update

Cormac Weldon and Chris Kent managers of Artemis Funds (Lux) – US Select, report on the fund over the quarter to 31 March 2024 and the outlook.

Source for all information: Artemis as at 31 March 2024 unless otherwise stated.

The fund returned 16.5% in US dollar terms, outperforming its benchmark, the S&P 500 index, which returned 10.6% and its peer group (the IA North America average), which returned 11.0%.

Ignoring the speedbumps…

The S&P 500 was remarkably resilient over the first quarter of 2024, shrugging off a shift in monetary policy stance brought about by elements of inflation that were more stubborn and an economy that was performing well. We also saw a regional banking scare and an increase in geopolitical tensions.

The index shrugged off these fears, posting 22 new all times highs and was only the eighth time since 1950 that it achieved back-to-back quarters of over 10% returns. Strength was supported by technology shares, in particular Nvidia which achieved an over 80% return (in US dollar) over the 3-month period, taking its market cap to $2.6trn. It is worth mentioning that we saw a broader contribution to returns than in 2023, with 10 out of 11 sectors being positive over the quarter1.

Stock selection drives outperformance:

As is our aim, the fund’s performance over the period was driven by stock selection, with sector allocation marginally detracting. Positive stock selection came from within technology, industrials, and consumer discretionary.

A poisoned Apple?

We maintained an underweight position in Apple over the period.

Our thesis on Apple is driven by what we see as a company that has meagre growth prospects and that are overly reliant on one product, the iPhone. It is therefore sensitive to a softening in demand which of late has come from China, where Apple is experiencing an increase in competition from the likes of Huawei, and a general hostility towards Western companies.

Despite the fundamental performance of Apple stalling, the company still holds a lofty valuation of around 26x P/E. Our underweight in the company proved to be our top relative contributor to performance over the period.

Meta continues to deliver

In contrast to Apple, we are overweight Meta, where we see a company that has reengineered its business through cost discipline and bolstered by the integration of AI within its advertising business. Following Apple’s adjustment of its privacy settings on its operating system in 2021, Meta’s ad revenue significantly declined due to its reduced ability to target users. What few realised was that Meta owned one of the fastest supercomputers ever built (the AI Research SuperCluster2) which was perfectly suited to regaining most of its signal and targeting ability through the use of AI. This acted as a significant support to the share price as ad revenue recovered.

The rest...

Regular names in our quarterly commentaries continued to perform well which include Saia (the less than truckload company), Constellation Energy (the independent power producer), Western Digital (memory technology), and Eagle Materials (cement & wall boarding).

On the negative side

On the negative side there was nothing over the quarter that truly stood out. There was some weakness in two of our healthcare names, Zoetis and Humana. Zoetis is the animal health company where we see a long-term growth story underpinned by the recent launch of Librela, a pain medication for dogs. Humana was tracking towards our downside thesis, and we sold out of the position over the period. PG&E was our main detractor over the period.

Activity – Adding Norfolk Southern, Allstate and Core & Main

We added Norfolk Southern, the rail freight business, where we see a cyclical recovery combined with revenue growth, margin harmonisation, and share buy backs. We have also initiated a position in Allstate, the insurance business, which stands to benefit from a very positive auto insurance pricing market.

We continued to add to our position in Core & Main. The company distributes pipes and fittings used in water and waste-water applications to municipal customers and companies involved in residential and non-residential construction. Water infrastructure in the US has been underinvested in for years and has started to receive funding, including from the infrastructure bill. In addition, we have a long-term bullish view on both residential and non-residential construction which should support a robust volume outlook for the company. The company has also been able to allocate capital to make accretive acquisitions and we expect this to continue.

Taking profits in strong performers

On the sell side, we have trimmed some of our better performing stocks such as TFI International, the trucking company, and Eagle Materials, the cement business.

Outlook – Still finding attractive opportunities

Despite the strong performance of the index and the fund at the start of 2024, we remain optimistic about the prospects as we move into the second quarter of the year. The economy looks to be in fine shape, despite at the margin there being some signs of fraying. We are aware that the interest rate picture remains uncertain, and we are therefore not wedded to a particular economic outcome. We focus on the microeconomics of companies to find opportunities, and as we see It, there is still a very healthy pipeline of ideas coming from a wide range of sectors.

1Source: https://www.spglobal.com/spdji/en/commentary/article/us-equities-market-attributes
2Introducing Meta’s Next-Gen AI Supercomputer | Meta (fb.com)

 

Discrete performance, 12 months to 31 March
2024 2023 2022 2021 2020  2019 2018 2017 2016 2015
Artemis Funds (Lux) – US Select 46.0% -16.2% 6.1% 52.7% -3.0%  - - - - -
S&P 500 TR 29.9% -7.7% 15.65% 56.4% -7.0%  - - - - -
Past performance is not a guide to the future.
Source: Lipper Limited/Artemis from 31 December 2023 to 31 March 2024 for class I Acc USD
All figures show total returns with dividends and/or income reinvested, net of all charges.
Performance does not take account of any costs incurred when investors buy or sell the fund.
Returns may vary as a result of currency fluctuations if the investor's currency is different to that of the class.
Benchmark: S&P 500 TR; the benchmark is a point of reference against which the performance of the fund may be measured. Management of the fund is not restricted by this benchmark. The deviation from the benchmark may be significant and the portfolio of the fund may at times bear little or no resemblance to its benchmark.

Investment in a fund concerns the acquisition of units/shares in the fund and not in the underlying assets of the fund.

Reference to specific shares or companies should not be taken as advice or a recommendation to invest in them.

For information on sustainability-related aspects of a fund, visit the relevant fund page on this website.

For information about Artemis’ fund structures and registration status, visit artemisfunds.com/fund-structures

Any research and analysis in this communication has been obtained by Artemis for its own use. Although this communication is based on sources of information that Artemis believes to be reliable, no guarantee is given as to its accuracy or completeness.

Any statements are based on Artemis’ current opinions and are subject to change without notice. They are not intended to provide investment advice and should not be construed as a recommendation.

Third parties (including FTSE and Morningstar) whose data may be included in this document do not accept any liability for errors or omissions. For information, visit artemisfunds.com/third-party-data.

Important information
The intention of Artemis’ ‘investment insights’ articles is to present objective news, information, data and guidance on finance topics drawn from a diverse collection of sources. Content is not intended to provide tax, legal, insurance or investment advice and should not be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security or investment by Artemis or any third-party. Potential investors should consider the need for independent financial advice. Any research or analysis has been procured by Artemis for its own use and may be acted on in that connection. The contents of articles are based on sources of information believed to be reliable; however, save to the extent required by applicable law or regulations, no guarantee, warranty or representation is given as to its accuracy or completeness. Any forward-looking statements are based on Artemis’ current opinions, expectations and projections. Articles are provided to you only incidentally, and any opinions expressed are subject to change without notice. The source for all data is Artemis, unless stated otherwise. The value of an investment, and any income from it, can fall as well as rise as a result of market and currency fluctuations and you may not get back the amount originally invested.